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ANTERIOR INTEROSSEOUS MONONEUROPATHY
ASSOCIATED WITH HEV INFECTION
Hepatitis E infection has been associated with several
neurologic complications, such as Guillain–Barré
syndrome, neuralgic amyotrophy, and meningoen-
cephalitis/myelitis.1 We describe a case of subacute
anterior interosseous mononeuropathy associated
with acute hepatitis E virus (HEV) infection.
A 25-year-old man without a significant medical
history or drug intake consulted because of weakness
in the right thumb. The weakness was first noticed by
the inability to swipe on his smartphone upon awak-
ening. That day at work, the weakness was particu-
larly troublesome because of the inability to handle
a pipette since flexion of the distal phalanx of the right
thumb was severely compromised. He had no sensory
disturbances. There was no preceding trauma. Dur-
ing the three days before onset of neurologic symp-
toms the patient experienced mild flu-like
symptoms (fever, muscle pain). Clinical investigation
at the day of symptom onset revealed isolated paresis
(Medical Research Council scale score 2/5) of flexion
of the distal phalanx of the right thumb (pincer move-
ment), compatible with a selective weakness of the
flexor pollicis longus muscle. Sensory examination
was unremarkable, and deep tendon reflexes were
normal. Electromyography (EMG) which was per-
formed 6 days after symptom onset revealed a severely
decreased recruitment of motor units in the right
flexor pollicis longus muscle, indicating dysfunction
of the anterior interosseous nerve. Other C8-T1
innervated muscles were normal. Nerve conduction
studies were unremarkable. MRI of the right brachial
plexus was unremarkable. Biochemical analysis re-
vealed positive HEV immunoglobulin G (IgG) and
IgM, but was furthermore completely normal includ-
ing alanine and aspartate transaminases. HEV RNA
was detected in blood with RealStar HEV RT-PCR
kit 1.0 (Altona Diagnostics—performed at WIV-
ISP). Based on the clinical picture and EMG findings,
anterior interosseous neuropathy was considered the
most likely diagnosis. However, since peripheral
nerve ultrasound or MR neurography has not been
performed, the exact localization of neuropathy is
unclear. As such, a fascicular motor lesion of the
median nerve trunk cannot be excluded.2 Because
of the positive HEV serology, the patient was treated
with intravenous corticosteroids (methylprednisolone
1 g for 3 days). A few days later, the patient had mild
pain in the right forearm, yet over the course of sev-
eral weeks, there was a gradual and total recovery of
function in the right thumb.
The most common postinfectious complications
of HEV infection are Guillain–Barré syndrome and
neuralgic amyotrophy.3–5 To our knowledge, this
patient is the first described to have peripheral
mononeuropathy, in particular subacute anterior in-
terosseous mononeuropathy, following an acute HEV
infection. Other mononeuropathies associated with
HEV infection include facial palsy and vestibular
neuritis.1 As such, this case expands the spectrum of
HEV-associated neuropathies and suggests inclusion
of HEV serology testing in the diagnostic workup of
patients with peripheral mononeuropathy. Since this
case merely provides a factual association between
HEV and peripheral mononeuropathy, causality
needs to be investigated further.
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